https://nl.marketscreener.com/koers/aandeel/NABRIVA-THERAPEUTICS-PLC-37853840/nieuws/Nabriva-Therapeutics-plc-voltooit-de-patienteninschrijving-in-Fase-1-studie-van-XENLETA-R-lefamul-41293487/?utm_source=telegram&utm_medium=social&utm_campaign=share